AstraZeneca’s Zurampic Received Green Signal from US FDA
The U.S. FDA on 23rd Dec 2015 accepted Zurampic (lesinurad) to treat higher levels of uric acid in the blood
Read moreThe U.S. FDA on 23rd Dec 2015 accepted Zurampic (lesinurad) to treat higher levels of uric acid in the blood
Read moreIndia based drug maker Dr Reddy’s has filled out a lawsuit in a US court against Anglo-Swedish drug giant AstraZeneca
Read moreA phase 1, single-blind, randomized, placebo-controlled trial started by Palatin Technologies is aimed at evaluating the efficiency of AZD282 for
Read more